1.      Albanese A, Bhatia K, Bressman SB, et al. Phenomenology and classification of dystonia: A consensus update. Mov Disord. 2013;28(7):863-873. doi:10.1002/mds.25475

2.      Albanese A, Valente EM, Romito LM, Bellacchio E, Elia AE, Dallapiccola B. The PINK1 phenotype can be indistinguishable from idiopathic Parkinson disease. Neurology. 2005;64(11):1958-1960. doi:10.1212/01.WNL.0000163999.72864.FD

3.      Baizabal-Carvallo JF, Baizabal JF. Chorea in childhood. Accessed November 30, 2025. https://www.medlink.com/articles/chorea-in-childhood

4.      Cans C. Surveillance of cerebral palsy in Europe: a collaboration of cerebral palsy surveys and registers. Dev Med Child Neurol. 2000;42(12):816-824. doi:10.1111/j.1469-8749.2000.tb00695.x

5.      Eltahawy HA, Saint-Cyr J, Giladi N, Lang AE, Lozano AM. Primary dystonia is more responsive than secondary dystonia to pallidal interventions: outcome after pallidotomy or pallidal deep brain stimulation. Neurosurgery. 2004;54(3):613-621.

6.      Gerber MA, Baltimore RS, Eaton CB, et al. Prevention of Rheumatic Fever and Diagnosis and Treatment of Acute Streptococcal Pharyngitis: A Scientific Statement From the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: Endorsed by the American Academy of Pediatrics. Circulation. 2009;119(11):1541-1551. doi:10.1161/CIRCULATIONAHA.109.191959

7.      Hayflick SJ, Penzien JM, Michl W, Sharif UM, Rosman NP, Wheeler PG. Cranial MRI changes may precede symptoms in Hallervorden-Spatz syndrome. Pediatr Neurol. 2001;25(2):166-169.

8.      Jonathan W. Mink and Terence D. Sanger. Movement Disorders: An Overview. In: Swaiman’s Pediatric Neurology: Principles and Practice: Sixth Edition. Vol 1. 6th ed. Elsevier Inc.; 2017:707-717.

9.      Koeppen AH, Dickson AC. Iron in the Hallervorden-Spatz syndrome. Pediatr Neurol. 2001;25(2):148-155.

10.  Kurian MA, Li Y, Zhen J, et al. Clinical and molecular characterisation of hereditary dopamine transporter deficiency syndrome: an observational cohort and experimental study. Lancet Neurol. 2011;10(1):54-62.

11.  Lee JH, Berkowitz RJ, Choi BJ. Oral self-mutilation in the Lesch-Nyhan syndrome. J Dent Child. 2002;69(1):66-69.

12.  Nardocci N, Fernandez-Alvarez E. Movement Disorders in Children: A Clinical Update with Video Recordings. Vol 17. John Libbey; 2007.

13.  Paz JA, Silva CA, Marques-Dias MJ. Randomized double-blind study with prednisone in Sydenham’s chorea. Pediatr Neurol. 2006;34(4):264-269.

14.  Prevalence of cerebral palsy in Turkish children between ... - Google Akademik. Accessed November 30, 2025. https://scholar.google.com/scholar?hl=tr&as_sdt=0%2C5&q=Prevalence+of+cerebral+palsy+in+Turkish+children+between+...&btnG=

15.  Sanger TD, Chen D, Delgado MR, et al. Definition and classification of negative motor signs in childhood. Pediatrics. 2006;118(5):2159-2167.

16.  Sanger TD, Chen D, Fehlings DL, et al. Definition and classification of hyperkinetic movements in childhood. Mov Disord. 2010;25(11):1538-1549. doi:10.1002/mds.23088

17.  Sanger TD, Delgado MR, Gaebler-Spira D, Hallett M, Mink JW, Disorders TF on CM. Classification and definition of disorders causing hypertonia in childhood. Pediatrics. 2003;111(1):e89-e97.

18.  Schlaggar BL, Mink JW. Movement disorders in children. Pediatr Rev. 2003;24(2):39-51.

19.  Singer HS, Mink JW, Gilbert DL, Jankovic J. Movement Disorders in Childhood. Academic press; 2015. Accessed October 29, 2025. https://books.google.com/books?hl=tr&lr=&id=bdGcBAAAQBAJ&oi=fnd&pg=PP1&dq=%22movement+disorders%22++in+childhood&ots=RD_4Op1d4M&sig=K3mr2oUxJ5QpChwPtTU-hp4aOho

20.  Umemura A, Jaggi JL, Dolinskas CA, Stern MB, Baltuch GH. Pallidal deep brain stimulation for longstanding severe generalized dystonia in Hallervorden—Spatz syndrome: case report. J Neurosurg. 2004;100(4):706-709.